- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
短期的强势行情可能结束，投资者及时短线卖出、离场观望为宜。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有488家主力机构披露2025-06-30报告期持股数据，持仓量总计7.49亿股，占流通A股48.56%
- 波段诊断：
-
技术面诊股
诊断结果：5.2技术面打败了12%的股票
技术面评分前10的股票
近期的平均成本为18.25元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为18.25元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"18.25","date":1768121973,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑输行业平均水平。
[{"date":"2026.01.12","stock":"0.49","trade":"0.28","ind":"1.09"},{"date":"2026.01.09","stock":"-0.38","trade":"1.86","ind":"0.92"},{"date":"2026.01.08","stock":"-0.71","trade":"1.15","ind":"-0.07"},{"date":"2026.01.07","stock":"-2.02","trade":"0.44","ind":"0.05"},{"date":"2026.01.06","stock":"1.40","trade":"0.51","ind":"1.50"},{"date":"2026.01.05","stock":"2.26","trade":"3.09","ind":"1.38"},{"date":"2025.12.31","stock":"-0.98","trade":"-0.07","ind":"0.09"},{"date":"2025.12.30","stock":"0.55","trade":"-0.48","ind":"-0.00"},{"date":"2025.12.29","stock":"-3.35","trade":"-1.13","ind":"0.04"},{"date":"2025.12.26","stock":"-0.16","trade":"-0.41","ind":"0.10"},{"date":"2025.12.25","stock":"-1.05","trade":"0.35","ind":"0.47"},{"date":"2025.12.24","stock":"-2.06","trade":"0.28","ind":"0.53"},{"date":"2025.12.23","stock":"0.52","trade":"-0.30","ind":"0.07"},{"date":"2025.12.22","stock":"0.68","trade":"0.14","ind":"0.69"},{"date":"2025.12.19","stock":"5.03","trade":"1.80","ind":"0.36"},{"date":"2025.12.18","stock":"1.10","trade":"0.51","ind":"0.16"},{"date":"2025.12.17","stock":"4.99","trade":"0.69","ind":"1.19"},{"date":"2025.12.16","stock":"-5.01","trade":"-2.00","ind":"-1.11"},{"date":"2025.12.15","stock":false,"trade":"-1.10","ind":"-0.55"},{"date":"2025.12.12","stock":"2.37","trade":"-0.50","ind":"0.41"},{"date":"2025.12.11","stock":"-0.45","trade":"-0.87","ind":"-0.70"}]
ST人福,上证指数,化学制药指数
压力支撑
该股压力位为18.22元，支撑位为18.13元。
[{"text":"\u538b\u529b\u4f4d","value":"18.22","date":1768147200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"18.13","date":1768147200,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.1资金面打败了4%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：01月12日 18:29
| 机构今日流向(万元) | -1707.30 | 机构5日流向(万元) | -1367.96 |
| 机构10日流向(万元) | -2141.99 | 机构20日流向(万元) | -4354.27 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少7424.5万股，其中基金净减仓63家，主力净减仓116家，请投资者中长期谨慎为宜。
截止2025-06-30，共488家主力机构（基金481家，信托公司1家，一般法人6家），持仓量总计74930.18万股，占流通A股48.56%
其中，基金持仓与2024-12-31相比：
增仓：107家 ，增持 2536.75万股
减仓：170家 ，减持 6375.21万股
新出现在主力名单中：175家 ，持有40175.66万股
从主力名单中消失：291家 ，原持有43511.58万股
其中，基金持仓与2024-12-31相比：
增仓：107家 ，增持 2536.75万股
减仓：170家 ，减持 6375.21万股
新出现在主力名单中：175家 ，持有40175.66万股
从主力名单中消失：291家 ，原持有43511.58万股
消息面诊股
诊断结果：4.3消息面打败了2%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 人福医药创新软膏Ib期临床完成首例受试者入组
2026-01-09 - 又一家国内头部药企，进入AI新药研发
2026-01-09 - 解开指数样本调整的“市场密码”
2026-01-09 - 即将生效！A股重要指数调整
2026-01-06 - 中证指数：中证1000等指数样本临时调整
2026-01-06 - 3月末银行扎堆晒“成绩单” 2026机构仍看好银行
2026-01-06 - 人福医药1类创新药HW221043片获批临床
2026-01-06 - ST人福：拟用于晚期实体瘤治疗的HW221043片
2026-01-05 - 21个独家中成药火了！倍特飙涨145%，广药称霸双
2025-12-31 - ST人福：公司2021年限制性股票激励计划的实施严
2025-12-31
消息列表
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-12-30 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-12-29 |
| 一般消息 | 重大事项 | 关联交易 | 2025-12-25 |
| 利空 | 上市变动 | 特别处理ST | 2025-12-16 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-11-08 |
| 一般消息 | 重大事项 | 关联交易 | 2025-10-14 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-08-28 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-28 |
| 一般消息 | 资产重组 | 公司股权转让 | 2025-08-01 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-07-30 |
| 一般消息 | 高管变动 | 退休 | 2025-07-02 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 重大事项 | 关联交易 | 2025-06-21 |
| 一般消息 | 高管变动 | 个人原因(退休) | 2025-06-09 |
| 一般消息 | 重大事项 | 公司股东股份解冻 | 2025-05-01 |
| 利好 | 分红转增 | 10派3.20元(含税) | 2025-04-29 |
| 一般消息 | 高管变动 | 委员会调整 | 2025-04-22 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-02-21 |
| 一般消息 | 重大事项 | 关联交易 | 2025-02-19 |
| 一般消息 | 高管变动 | 因工作调整 | 2025-01-24 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 3条 | 0条 | 3条 |
行业面诊股
诊断结果：7.0行业面打败了87%的股票
化学制药行业最新资金流向
近10日来该行业走势明显向上，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势明显向上，接近大盘。
[{"date":"2026.01.12","price":"1.09","value":"0.28"},{"date":"2026.01.09","price":"0.92","value":"1.86"},{"date":"2026.01.08","price":"-0.07","value":"1.15"},{"date":"2026.01.07","price":"0.05","value":"0.44"},{"date":"2026.01.06","price":"1.50","value":"0.51"},{"date":"2026.01.05","price":"1.38","value":"3.09"},{"date":"2025.12.31","price":"0.09","value":"-0.07"},{"date":"2025.12.30","price":"-0.00","value":"-0.48"},{"date":"2025.12.29","price":"0.04","value":"-1.13"},{"date":"2025.12.26","price":"0.10","value":"-0.41"},{"date":"2025.12.25","price":"0.47","value":"0.35"},{"date":"2025.12.24","price":"0.53","value":"0.28"},{"date":"2025.12.23","price":"0.07","value":"-0.30"},{"date":"2025.12.22","price":"0.69","value":"0.14"},{"date":"2025.12.19","price":"0.36","value":"1.80"},{"date":"2025.12.18","price":"0.16","value":"0.51"},{"date":"2025.12.17","price":"1.19","value":"0.69"},{"date":"2025.12.16","price":"-1.11","value":"-2.00"},{"date":"2025.12.15","price":"-0.55","value":"-1.10"},{"date":"2025.12.12","price":"0.41","value":"-0.50"},{"date":"2025.12.11","price":"-0.70","value":"-0.87"}]
上证指数,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 必贝特 | 48.92% | 46.77% | 6.0分 |
| 2 | 奥锐特 | 39.30% | 18.37% | 6.6分 |
| 3 | 前沿生物 | 39.10% | 32.41% | 6.2分 |
| 4 | 宏源药业 | 34.89% | -8.68% | 4.3分 |
| 5 | 上海谊众 | 30.88% | 22.67% | 6.7分 |
| 6 | 亚虹医药 | 25.75% | 7.42% | 6.0分 |
| 8 | 海翔药业 | 22.92% | 15.09% | 6.4分 |
| 10 | 微芯生物 | 20.84% | 6.84% | 6.3分 |
| 12 | 北陆药业 | 19.19% | 5.01% | 6.1分 |
| 14 | 汇宇制药 | 15.44% | 18.04% | 6.6分 |
| 16 | 科源制药 | 15.04% | 6.64% | 5.6分 |
| 18 | 广济药业 | 13.81% | 9.83% | 6.1分 |
| 20 | 川宁生物 | 12.40% | 6.86% | 5.8分 |
| 22 | 泰恩康 | 11.60% | 6.42% | 5.5分 |
| 24 | 舒泰神 | 11.34% | 5.42% | 5.4分 |
| 26 | 莱美药业 | 10.46% | 0.19% | 5.1分 |
| 28 | 东亚药业 | 10.29% | 11.62% | 5.7分 |
| 30 | 溢多利 | 9.61% | 3.73% | 5.2分 |
| 32 | 盟科药业 | 8.94% | 5.85% | 6.1分 |
| 34 | 仟源医药 | 8.86% | 5.81% | 6.3分 |
| 36 | 国邦医药 | 8.61% | 1.90% | 6.4分 |
| 38 | 圣诺生物 | 8.08% | 13.35% | 6.3分 |
| 40 | 迪哲医药 | 7.57% | 7.99% | 6.4分 |
| 42 | 诚意药业 | 7.16% | 4.79% | 6.2分 |
| 44 | 益方生物 | 7.05% | 10.60% | 6.2分 |
| 46 | 奥翔药业 | 6.92% | 0.89% | 6.0分 |
| 48 | 苑东生物 | 6.69% | 2.97% | 6.1分 |
| 50 | *ST景峰 | 6.36% | 18.70% | 5.4分 |
| 52 | 科伦药业 | 6.13% | 12.49% | 6.4分 |
| 54 | 本立科技 | 6.11% | 1.91% | 6.0分 |
| 56 | 尔康制药 | 5.70% | 4.21% | 5.6分 |
| 58 | - | 5.60% | 6.45% | 分 |
| 60 | 吉贝尔 | 5.39% | 0.30% | 5.5分 |
| 62 | 新天地 | 5.25% | 2.98% | 5.7分 |
| 64 | - | 5.19% | 4.84% | 分 |
| 66 | 海欣股份 | 5.09% | 5.99% | 5.9分 |
| 68 | 新和成 | 5.01% | 0.96% | 5.9分 |
| 70 | 海森药业 | 4.89% | 2.78% | 5.6分 |
| 72 | 海普瑞 | 4.84% | 1.98% | 6.4分 |
| 74 | 博瑞医药 | 4.72% | 1.08% | 5.6分 |
| 76 | 东诚药业 | 4.59% | 4.21% | 6.0分 |
| 78 | 广生堂 | 4.25% | -1.58% | 4.6分 |
| 80 | 兴齐眼药 | 4.05% | 0.33% | 6.4分 |
| 82 | 华海药业 | 3.85% | 3.38% | 5.9分 |
| 84 | 千红制药 | 3.75% | 1.97% | 5.5分 |
| 86 | 德展健康 | 3.64% | 1.27% | 4.6分 |
| 88 | 健友股份 | 3.56% | 3.90% | 6.0分 |
| 90 | 华纳药厂 | 3.37% | 2.37% | 5.5分 |
| 92 | 誉衡药业 | 3.22% | 1.26% | 5.8分 |
| 94 | 永安药业 | 3.14% | 2.47% | 5.0分 |
| 96 | ST人福 | 2.70% | -1.24% | 5.2分 |
| 98 | 辰欣药业 | 2.43% | 1.98% | 5.2分 |
| 100 | - | 2.24% | 3.49% | 分 |
| 102 | 丰原药业 | 1.88% | 1.72% | 5.5分 |
| 104 | 华北制药 | 1.79% | 1.97% | 5.6分 |
| 106 | 莎普爱思 | 1.71% | 2.25% | 5.5分 |
| 108 | - | 1.63% | 4.08% | 分 |
| 110 | 津药药业 | 1.45% | 1.21% | 5.5分 |
| 112 | 华仁药业 | 1.23% | 1.86% | 5.4分 |
| 114 | 普洛药业 | 1.06% | -0.37% | 5.0分 |
| 116 | 福安药业 | 0.89% | 0.44% | 4.8分 |
| 118 | 亨迪药业 | 0.78% | 3.26% | 5.4分 |
| 120 | 恒瑞医药 | 0.71% | 1.22% | 6.8分 |
| 122 | 东北制药 | 0.37% | 1.89% | 5.8分 |
| 124 | 鲁抗医药 | 0.11% | 1.96% | 5.4分 |
| 126 | 北大医药 | -0.46% | 2.35% | 5.4分 |
| 128 | 哈药股份 | -0.56% | 1.42% | 5.4分 |
| 130 | 新华制药 | -0.74% | 1.45% | 5.3分 |
| 132 | 同和药业 | -0.77% | 1.44% | 5.3分 |
| 134 | 金城医药 | -0.85% | 5.08% | 4.9分 |
| 136 | 金石亚药 | -1.90% | 3.03% | 5.0分 |
| 138 | 神奇制药 | -2.34% | 1.79% | 5.8分 |
| 140 | ST诺泰 | -2.67% | 0.16% | 4.6分 |
| 142 | 健康元 | -3.13% | 3.25% | 5.6分 |
| 144 | *ST赛隆 | -3.76% | 1.84% | 5.1分 |
| 146 | 天新药业 | -4.15% | -0.18% | 5.1分 |
| 148 | 百利天恒 | -4.99% | 6.23% | 5.4分 |
| 150 | 海南海药 | -6.51% | 3.03% | 4.6分 |
| 152 | 海创药业 | -7.65% | 3.44% | 5.9分 |
| 154 | 信立泰 | -9.36% | 6.47% | 6.1分 |
| 156 | 常山药业 | -15.41% | -6.00% | 3.6分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 安信证券 | 2012-09-04 | 增持 | 增持 |
| 长江证券 | 2012-09-02 | 增持 | - |
更多>>行业资讯
- 2012-09-13北京药监局通知全市停用8家企业中药饮片
- 2012-09-13澳洲股指周四收跌0.5% 医疗及消费股领跌
- 2012-09-13基层中医药服务能力将获提升
- 2012-09-132012中国医疗卫生产业发展论坛召开
- 2012-09-13医药行业：媒体称新版基药目录品种将扩至700个
- 2012-09-13陕西县级公立医院改革全面推开
- 2012-09-138月中山CPI 环比涨0.1%
- 2012-09-13中金公司：医药板块选股坚持“稳健业绩+成长空间预期
- 2012-09-13澳洲股指周四盘初跌0.5% 医疗及消费股领跌
- 2012-09-13感冒药“实名制”个人信息易“走光”？ 法国立法严管
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 29/217 ， 75/217。
[{"date":"2025-09-30","value":"9.24","vol":"1.51"},{"date":"2025-06-30","value":"6.42","vol":"1.23"},{"date":"2025-03-31","value":"3.02","vol":"-0.14"},{"date":"2024-12-31","value":"7.67","vol":"19.62"},{"date":"2024-09-30","value":"9.11","vol":"4.62"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
9.24 | 6.42 | 3.02 | 7.67 | 9.11 |
| 行业(%) | 1.51 | 1.23 | -0.14 | 19.62 | 4.62 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"47.95","vol":"49.36"},{"date":"2025-06-30","value":"48.18","vol":"49.33"},{"date":"2025-03-31","value":"48.56","vol":"49.14"},{"date":"2024-12-31","value":"44.55","vol":"50.78"},{"date":"2024-09-30","value":"46.76","vol":"50.61"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
47.95 | 48.18 | 48.56 | 44.55 | 46.76 |
| 行业(%) | 49.36 | 49.33 | 49.14 | 50.78 | 50.61 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 95/217 ， 62/217。
[{"date":"2025-09-30","value":"-6.58","vol":"142.98"},{"date":"2025-06-30","value":"-6.20","vol":"79.25"},{"date":"2025-03-31","value":"-3.61","vol":"-0.67"},{"date":"2024-12-31","value":"3.71","vol":"18.07"},{"date":"2024-09-30","value":"5.70","vol":"45.94"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-6.58 | -6.20 | -3.61 | 3.71 | 5.70 |
| 行业(%) | 142.98 | 79.25 | -0.67 | 18.07 | 45.94 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"6.22","vol":"-3.26"},{"date":"2025-06-30","value":"3.92","vol":"58.57"},{"date":"2025-03-31","value":"11.09","vol":"-11.22"},{"date":"2024-12-31","value":"-37.70","vol":"-22.02"},{"date":"2024-09-30","value":"-10.12","vol":"-34.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
6.22 | 3.92 | 11.09 | -37.70 | -10.12 |
| 行业(%) | -3.26 | 58.57 | -11.22 | -22.02 | -34.66 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 20/217 ， 30/217。
[{"date":"2025-09-30","value":"0.49","vol":"0.31"},{"date":"2025-06-30","value":"0.33","vol":"0.21"},{"date":"2025-03-31","value":"0.17","vol":"0.10"},{"date":"2024-12-31","value":"0.70","vol":"0.43"},{"date":"2024-09-30","value":"0.52","vol":"0.33"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.49 | 0.33 | 0.17 | 0.70 | 0.52 |
| 行业(次) | 0.31 | 0.21 | 0.10 | 0.43 | 0.33 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"2.65","vol":"1.94"},{"date":"2025-06-30","value":"1.78","vol":"1.30"},{"date":"2025-03-31","value":"0.90","vol":"0.66"},{"date":"2024-12-31","value":"3.93","vol":"3.19"},{"date":"2024-09-30","value":"2.70","vol":"2.12"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.65 | 1.78 | 0.90 | 3.93 | 2.70 |
| 行业(次) | 1.94 | 1.30 | 0.66 | 3.19 | 2.12 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"13.57","vol":"4.43"},{"date":"2025-06-30","value":"20.17","vol":"2.74"},{"date":"2025-03-31","value":"-5.49","vol":"-26.98"},{"date":"2024-12-31","value":"10.67","vol":"-373.99"},{"date":"2024-09-30","value":"10.30","vol":"-9.47"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 13.57 | 20.17 | -5.49 | 10.67 | 10.30 |
| 行业 | 4.43 | 2.74 | -26.98 | -373.99 | -9.47 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.74","vol":"1.73"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.98","vol":"2.00"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.74 | - | 0.98 | - |
| 行业 | 0.00 | 1.73 | 0.00 | 2.00 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 22/217 ， 38/217。
[{"date":"2025-09-30","value":"1.69","vol":"3.50"},{"date":"2025-06-30","value":"1.54","vol":"3.69"},{"date":"2025-03-31","value":"1.49","vol":"3.61"},{"date":"2024-12-31","value":"1.49","vol":"3.36"},{"date":"2024-09-30","value":"1.49","vol":"3.67"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.69 | 1.54 | 1.49 | 1.49 | 1.49 |
| 行业 | 3.50 | 3.69 | 3.61 | 3.36 | 3.67 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.34","vol":"2.75"},{"date":"2025-06-30","value":"1.24","vol":"2.90"},{"date":"2025-03-31","value":"1.19","vol":"2.83"},{"date":"2024-12-31","value":"1.17","vol":"2.65"},{"date":"2024-09-30","value":"1.15","vol":"2.93"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.34 | 1.24 | 1.19 | 1.17 | 1.15 |
| 行业 | 2.75 | 2.90 | 2.83 | 2.65 | 2.93 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 38/217 ， 44/217。
[{"date":"2025-09-30","value":"40.53","vol":"33.63"},{"date":"2025-06-30","value":"43.00","vol":"33.66"},{"date":"2025-03-31","value":"42.59","vol":"33.90"},{"date":"2024-12-31","value":"43.32","vol":"34.07"},{"date":"2024-09-30","value":"43.72","vol":"32.87"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
40.53 | 43.00 | 42.59 | 43.32 | 43.72 |
| 行业(%) | 33.63 | 33.66 | 33.90 | 34.07 | 32.87 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.79","vol":"0.94"},{"date":"2025-06-30","value":"0.88","vol":"0.88"},{"date":"2025-03-31","value":"0.87","vol":"1.47"},{"date":"2024-12-31","value":"0.90","vol":"0.84"},{"date":"2024-09-30","value":"0.91","vol":"0.73"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.79 | 0.88 | 0.87 | 0.90 | 0.91 |
| 行业(%) | 0.94 | 0.88 | 1.47 | 0.84 | 0.73 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 招商证券 | 2025-12-29 | 买入 | |
| 太平洋 | 2025-11-04 | 买入 | |
| 海通国际 | 2025-11-03 | 增持 | |
| 国泰海通证券 | 2025-10-31 | 增持 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"13.90","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"24.84","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"21.34","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"13.30","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"21.52","blueLineValue":"1.32","type":"YC"}]